A carregar...
ERCC1_202 Is A Prognostic Biomarker in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
Purpose: To develop a qPCR method to examine the 202 isoform of excision repair cross-complementation group 1 (ERCC1_202) and to evaluate its clinical utility as a predictive biomarker for platinum-based chemotherapy in non-small cell lung cancer (NSCLC). Methods: The relative complementary DNA (cDN...
Na minha lista:
| Publicado no: | J Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5604217/ https://ncbi.nlm.nih.gov/pubmed/28928874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.19897 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|